Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
new york blog main
3
×
startups
3
×
boston
boston blog main
boston top stories
national top stories
new york top stories
antisense oligonucleotide
aphelion capital
azacitidine
benzodiazepines
beta-thalassemia
biogen
biolinq
blackstone group
blackstone life sciences
clinical trials
columbia university
continuous glucose monitoring
dacogen
david goldstein
deals
decitabine
depression
diabetes
dna
epi4k
epigenetics
epilepsy
epizyme
essential tremor
farydak
flagship pioneering
fulcrum therapeutics
hikma
insulated genomic domains
investing
What
new
3
×
research
3
×
aims
based
drugs
medicines
startup
adds
advance
approach
backed
biolinq
biosensor
biotech
called
cause
ceo
debuts
developing
diabetes
epigenetic
epigenetics
epilepsy
field
flagship’s
genes
genetic
glucose
including
investors
juvenile
links
marcio
million
monitoring
morning
mutations
neuro
omega
patch
Language
unset
Current search:
new
×
startups
×
" new york blog main "
×
research
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
